| Use of canakinumab in the cryopyrin-associated periodic syndrome HJ Lachmann, I Kone-Paut, JB Kuemmerle-Deschner, KS Leslie, ... New England Journal of Medicine 360 (23), 2416-2425, 2009 | 1017 | 2009 |
| Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes J Feldmann, AM Prieur, P Quartier, P Berquin, S Certain, E Cortis, ... The American Journal of Human Genetics 71 (1), 198-203, 2002 | 884 | 2002 |
| Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis N Ruperto, HI Brunner, P Quartier, T Constantin, N Wulffraat, G Horneff, ... New England Journal of Medicine 367 (25), 2396-2406, 2012 | 807 | 2012 |
| Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial N Ruperto, DJ Lovell, P Quartier, E Paz, N Rubio-Pérez, CA Silva, ... The Lancet 372 (9636), 383-391, 2008 | 661 | 2008 |
| A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic … P Quartier, F Allantaz, R Cimaz, P Pillet, C Messiaen, C Bardin, X Bossuyt, ... Annals of the rheumatic diseases 70 (5), 747-754, 2011 | 610 | 2011 |
| Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency B Boisson, E Laplantine, C Prando, S Giliani, E Israelsson, Z Xu, ... Nature immunology 13 (12), 1178-1186, 2012 | 470 | 2012 |
| Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type P Quartier, P Taupin, F Bourdeaut, I Lemelle, P Pillet, M Bost, J Sibilia, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2003 | 464 | 2003 |
| Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France T Lequerré, P Quartier, D Rosellini, F Alaoui, M De Bandt, O Mejjad, ... Annals of the rheumatic diseases 67 (3), 302-308, 2008 | 460 | 2008 |
| Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French autoimmunity and rituximab registry B Terrier, Z Amoura, P Ravaud, E Hachulla, R Jouenne, B Combe, ... Arthritis & Rheumatism 62 (8), 2458-2466, 2010 | 455 | 2010 |
| Canakinumab for the treatment of autoinflammatory recurrent fever syndromes F De Benedetti, M Gattorno, J Anton, E Ben-Chetrit, J Frenkel, ... New England Journal of Medicine 378 (20), 1908-1919, 2018 | 451 | 2018 |
| Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients N Milpied, B Vasseur, N Parquet, JL Garnier, C Antoine, P Quartier, ... Annals of Oncology 11, S113-S116, 2000 | 448 | 2000 |
| Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients S Dupuis-Girod, J Medioni, E Haddad, P Quartier, M Cavazzana-Calvo, ... Pediatrics 111 (5), e622-e627, 2003 | 412 | 2003 |
| Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients P Quartier, M Debré, J De Blic, R de Sauverzac, N Sayegh, N Jabado, ... The Journal of pediatrics 134 (5), 589-596, 1999 | 377 | 1999 |
| Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children M Grimaud, J Starck, M Levy, C Marais, J Chareyre, D Khraiche, ... Annals of intensive care 10, 1-5, 2020 | 376 | 2020 |
| Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children N Ouldali, J Toubiana, D Antona, E Javouhey, F Madhi, M Lorrot, ... Jama 325 (9), 855-864, 2021 | 364 | 2021 |
| Detection of interferon alpha protein reveals differential levels and cellular sources in disease MP Rodero, J Decalf, V Bondet, D Hunt, GI Rice, S Werneke, ... Journal of experimental medicine 214 (5), 1547-1555, 2017 | 350 | 2017 |
| Treating juvenile idiopathic arthritis to target: recommendations of an international task force A Ravelli, A Consolaro, G Horneff, RM Laxer, DJ Lovell, NM Wulffraat, ... Annals of the rheumatic diseases 77 (6), 819-828, 2018 | 330 | 2018 |
| Treatment of childhood autoimmune haemolytic anaemia with rituximab P Quartier, B Brethon, P Philippet, J Landman-Parker, A Fischer The Lancet 358 (9292), 1511-1513, 2001 | 322 | 2001 |
| Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study B Bader-Meunier, JB Armengaud, E Haddad, R Salomon, G Deschênes, ... The Journal of pediatrics 146 (5), 648-653, 2005 | 312 | 2005 |
| Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial HI Brunner, N Ruperto, Z Zuber, C Keane, O Harari, A Kenwright, P Lu, ... Annals of the rheumatic diseases 74 (6), 1110-1117, 2015 | 310 | 2015 |
